Currently offering SARS-CoV-2 Antigen and Antibody, D-Dimer and INR test capabilities, with a pipeline of over 30 tests across a range of assay technologies including enzyme, immunoassay, molecular and electrolyte assays. All carried out on one, easy to use device.
Explore Test MenuOur latest Cloud-based technology empowers healthcare professionals with effortless data reporting, analytics, and decision support.
Explore connectivityOur platform is designed to be affordable and accessible at the point of care
LumiraDx Achieves CE Mark for COVID-19 Antigen Test on Amira, its New Low-Cost Testing System
Thursday 9 June 2022
Read moreLumiraDx Receives CE Mark for Two Multiplex Tests: LumiraDx Dual-Target SARS-CoV-2 STAR Complete and LumiraDx SARS-CoV-2 & Flu A/B RNA STAR Complete
Wednesday 8 June 2022
Read moreLumiraDx Expands its Cardiovascular Testing Portfolio with CE Marking of its NT-proBNP Test and new Exclusion Claim for its D-Dimer Test
Thursday 2 June 2022
Read moreSupporting healthier lives, for individuals, communities and wider society
Enabling responsive, personal relationships between patients and care teams.
Controlling and reducing costs to help ease pressure on healthcare budgets.